Search

everythinglearnresearchcommunity

for

Search:↓

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Vitamins A, B3, C, D, and E can improve skin health and immunity.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Damage to hair follicle stem cells may cause permanent hair loss and scarring in PCA.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Lupus can cause hair loss and nail changes, with treatments available for both.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Cutting scalp biopsies in consecutive slices improves diagnosis of hair loss conditions.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Managing inflammation and using vitamins can improve PRP therapy for better hair growth.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

LC-OCT is an effective new method for diagnosing classic lichen planopilaris.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.